Leaders from the International Cooperation Center of the National Development and Reform Commission Visit Deep Harbour Cell Valley Healthcare and Technology Co., Ltd.

To thoroughly implement the strategic deployment on expanding high-level opening-up outlined at the Third Plenary Session of the 20th CPC Central Committee, actively promote orderly opening in the pharmaceutical and healthcare sectors, and assist in building a new system for an open economy at a higher level, the International Cooperation Center of the National Development and Reform Commission (NDCC) recently launched a special survey on new areas of opening-up in medicine and healthcare. Recently, a research team visited Deep Harbour Cell Valley Healthcare and Technology Co., Ltd., engaging in in-depth exchanges and discussions with the company's senior leadership on cutting-edge industry topics.

High-Level Research Team Focusing on Frontier Industry Issues

The survey was led by Qiu Aijun, Deputy Director of the International Cooperation Center of the NDCC. The team included Li Huaxiang, Deputy Director of the Consulting Research Division and Associate Researcher; Guo Fangcui, Assistant Researcher at the Low-Altitude Economy Research Office; and Shan Shiyao, Officer at the Major Events Division. Accompanying them were Zhang Fei, Deputy Director of the Foreign Investment Institute at the Chinese Academy of International Trade and Economic Cooperation (CAITEC) under the Ministry of Commerce and Associate Researcher, as well as Zhao Yue, a graduate student from Beijing Technology and Business University, who participated as a member of the research task force.

Grounded in national macro-strategies, the research team focused on the new landscape of opening-up in the pharmaceutical and healthcare sectors, aiming to provide research support for policy formulation and promote the sustainable and healthy development of the industry.

Deep Harbour Cell Valley Healthcare and Technology Co., Ltd. Extends Warm Welcome, Comprehensively Showcasing Corporate Strength

Deep Harbour Cell Valley Healthcare and Technology Co., Ltd. attached great importance to this visit. The company was personally received by its senior leaders, including Chairman Professor Shi Yuanyuan and Chief Medical Officer Professor David Kin Jin. During the symposium, Professor Shi Yuanyuan provided a comprehensive overview of the company's development history, strategic layout, and future plans. He highlighted the group's architecture, service modules, core products, and technological advantages and innovative achievements in cell therapy and health management, fully demonstrating the company's scientific research strength and development potential.

In-Depth Exchanges to Jointly Promote Industry Development

In the subsequent discussion session, both sides engaged in deep, pragmatic, and candid talks on hot topics regarding new areas of opening-up in the pharmaceutical and healthcare sectors. The agenda covered issues of high national concern, such as the implementation and execution of new opening-up policies. This exchange not only deepened the research team's understanding of the company's current status and needs but also provided first-hand materials and valuable references for subsequent policy formulation.

This survey activity by the International Cooperation Center of the NDCC not only reflects a high level of attention to new areas of opening-up in the pharmaceutical and healthcare sectors but also lays a solid foundation for making relevant policies more aligned with industrial realities and better serving the development of the real economy.

Taking this as an opportunity, Deep Harbour Cell Valley Healthcare and Technology Co., Ltd. will continue to uphold the spirit of openness and innovation, actively participate in government-related exchanges and cooperation, and contribute to building a globally competitive industrial ecosystem for cell therapy and health management. It is believed that under the joint efforts of the government and enterprises, the industry will usher in a more prosperous future, making greater contributions to enhancing people's health and well-being.